Diagnostic utility of flow cytometry based coated‐platelets assay as a biomarker to predict thrombotic or hemorrhagic phenotype in acute stroke. Issue 3 (21st June 2021)

• Record Type: Journal Article
• Authors: Dave, Rutvi Gautam; Geevar, Tulasi; Aaron, Sanjith; Ninan Benjamin, Rohit; Mammen, Joy; Kumar, Snehil; Vijayan, Ramya; Gowri, Mahasampath; Nair, Sukesh C
• Is Part Of: Cytometry. Volume 102:Issue 3(2022)
• Page Start: 246
• Page End: 253
• Publication Date: 2021-06-21
• Subjects: coated‐cell activation -- platelet -- flow cytometry -- intracerebral hemorrhage -- ischemic stroke -- platelet; Flow cytometry -- Diagnostic use -- Periodicals; Cytodiagnosis -- Periodicals; 616.07582
• DOI: 10.1002/cyto.b.22026
• Languages: English
• ISSNs: 1552-4949

Abstract

Abstract: Background: Coated‐platelets are sub‐population of platelets "coated" with highly procoagulant proteins and phosphatidylserine that sustains thrombin generation. They are produced upon dual agonist stimulation by collagen and thrombin. This study was conducted to assess if there was any difference in the levels of coated‐platelets in patients with primary intracranial hemorrhage (PICH) and ischemic stroke due to large artery atherosclerosis (LAA) as compared to healthy controls, and to see if coated‐platelet levels had any influence on the hemorrhagic transformation (HT) of ischemic stroke. Methods: Coated‐platelet levels were determined by flow cytometry using fluorescently tagged Annexin V antibody to identify phosphatidylserine exposed on the surface of platelets activated by dual agonists (convulxin and thrombin) in cross‐sectional cohort of 75 patients with stroke and 34 controls. Results: Patients with PICH ( n = 35) had significantly lower coated‐platelets than the controls (adjusted mean ± SE, 21.0 ± 1.9% vs. 36.1 ± 1.7%, p < 0.001), while patients with LAA ( n = 30) had significantly higher coated‐platelets than controls (adjusted mean ± SE, 51.9 ± 1.5% vs. 36.1 ± 1.7%, p < 0.001). Patients with subsequent HT of ischemic stroke ( n = 10) had significantly lower coated‐platelet levels at admission compared to those without HT (adjusted mean ± SE, 18.1 ± 2.6% vs. 51.9 ± 1.5%, p < 0.001). Conclusions: Coated‐platelet levels are significantly different in patients with hemorrhagic and ischemic stroke as compared with controls. Lower levels of coated‐platelets measured by flow cytometry may be earliest predictor of subsequent HT in patients with ischemic stroke even before the radiological changes suggestive of HT are visualized.